Papers

2

Total Citations

8

H-Index

2

About

Dr. Toshiki Kijima is a urologic surgeon whose research focuses on rare genitourinary tumors and minimally invasive surgical techniques. His work addresses the diagnostic and therapeutic challenges of uncommon prostate neoplasms, particularly stromal tumors of uncertain malignant potential (STUMP). In his most cited study (2020, 6 citations), Dr. Kijima demonstrated the utility of FDG-PET in surgical planning for prostate STUMP, a rare entity with variable clinical behavior ranging from indolent to aggressive sarcoma-like progression. This contribution provides critical guidance for managing diagnostically ambiguous cases where conventional imaging proves insufficient. Additionally, Dr. Kijima has advanced the field of minimally invasive urologic oncology through his development of gasless two-port access RoboSurgeon retroperitoneoscopic radical nephroureterectomy (2015, 2 citations), a technique that reduces surgical trauma while maintaining oncologic efficacy. His work bridges the gap between rare disease management and technological innovation in urologic surgery, offering practical solutions for complex clinical scenarios. Dr. Kijima’s research continues to inform surgical decision-making for challenging urologic malignancies, particularly where traditional approaches fall short.

Research Focus

Key Achievements

2
H-Index
2
Papers
8
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Case of prostate stromal tumour of uncertain malignant potential where positron emission tomography with 18F-fluorodeoxyglucose was useful for surgical planning
6 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Dokkyo Medical University, Tokyo Medical and Dental University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago